nach oben

Reactions Weekly

Erschienen in:

01.04.2023 | Case report

Celecoxib/escitalopram/trazodone

Jitteriness/anxiety syndrome followed by pharmacokinetic drug interaction: case report

Erschienen in: Reactions Weekly | Ausgabe 1/2023

Einloggen, um Zugang zu erhalten

Excerpt

Author Information

An event is serious (based on the ICH definition) when the patient outcome is&colon; Drug interaction

* death
* life-threatening
* hospitalisation
* disability
* congenital anomaly
* other medically important event

…

Shirata T, et al. Jitteriness/anxiety syndrome caused by coadministration of celecoxib, et al. selective COX-2 inhibitor, with escitalopram and trazodone in a patient with depression and spondylolisthesis. Neuropsychopharmacology Reports : Jan 2023. Available from: URL: http://doi.org/10.1002/npr2.12325

Titel: Celecoxib/escitalopram/trazodone
Jitteriness/anxiety syndrome followed by pharmacokinetic drug interaction: case report
Publikationsdatum: 01.04.2023
Verlag: Springer International Publishing
Erschienen in: Reactions Weekly / Ausgabe 1/2023
Print ISSN: 0114-9954
Elektronische ISSN: 1179-2051
DOI: https://doi.org/10.1007/s40278-023-36886-x

Springer Medizin

Excerpt

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 1/2023

Azathioprine/prednisolone

Azathioprine

Antibacterials/dopamine

Bevacizumab/human-papillomavirus-vaccine-recombinant-quadrivalent-Merck/MVA-p53

Multiple drugs

Alendronic-acid